• INTETUMUMAB chembl:CHEMBL1743032 Antineoplastic

    Alternate Names:

    CNTO-95
    CNTO-095
    INTETUMUMAB

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Trial Name CNTO-95
    Novel drug target Novel Target
    Mechanism of Interaction Integrin alpha-V/beta-5 antagonist

    Publications:

  • Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Trial Name CNTO-95
    Novel drug target Established target
    Mechanism of Interaction Integrin alpha-V/beta-1 antagonist

    Publications:

  • Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Integrin alpha-V/beta-6 antagonist

    Publications:

  • Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Integrin alpha-V/beta-3 antagonist
    Trial Name CNTO-95

    Publications:

  • Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Mechanism of Interaction Integrin alpha-V/beta-1 antagonist
    Direct Interaction yes

    Publications: